newsfilter
← Latest News
Business Wire·

Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025

TDP-43 CYTOPE® preclinical data demonstrates the potential of Prothena's CYTOPE technology as a novel modality for delivering large molecules into cells, enabling precise targeting of intracellular disease